What is B. Riley’s Estimate for KRMD FY2024 Earnings?

KORU Medical Systems, Inc. (NASDAQ:KRMD) – Equities researchers at B. Riley boosted their FY2024 EPS estimates for shares of KORU Medical Systems in a note issued to investors on Tuesday, January 14th. B. Riley analyst K. Bauser now expects that the company will post earnings of ($0.13) per share for the year, up from their previous forecast of ($0.14). The consensus estimate for KORU Medical Systems’ current full-year earnings is ($0.14) per share. B. Riley also issued estimates for KORU Medical Systems’ Q4 2024 earnings at ($0.03) EPS, Q4 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.09) EPS.

Several other research firms have also recently commented on KRMD. Craig Hallum boosted their price target on KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Lake Street Capital upped their target price on KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research report on Tuesday. Piper Sandler raised their price target on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday, November 14th. Finally, Canaccord Genuity Group lifted their price target on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $4.30.

KORU Medical Systems Stock Down 3.2 %

NASDAQ:KRMD opened at $3.94 on Thursday. The firm has a 50-day moving average of $3.75 and a two-hundred day moving average of $2.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37. KORU Medical Systems has a 1-year low of $1.98 and a 1-year high of $4.60.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of KRMD. XTX Topco Ltd acquired a new stake in shares of KORU Medical Systems during the 3rd quarter valued at approximately $34,000. Connor Clark & Lunn Investment Management Ltd. increased its stake in KORU Medical Systems by 77.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after purchasing an additional 26,860 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of KORU Medical Systems by 6.5% during the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after purchasing an additional 28,323 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of KORU Medical Systems in the 2nd quarter worth about $107,000. Finally, Empire Financial Management Company LLC acquired a new position in shares of KORU Medical Systems in the 3rd quarter valued at about $259,000. Institutional investors own 58.60% of the company’s stock.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.